ID: ALA5207692
Chembl Id: CHEMBL5207692
PubChem CID: 168297680
Max Phase: Preclinical
Molecular Formula: C20H29ClN4O2
Molecular Weight: 356.47
Associated Items:
Canonical SMILES: CCCC1CNCc2c1[nH]c(=O)c(C#N)c2N1CCC2(CCOC2)CC1.Cl
Standard InChI: InChI=1S/C20H28N4O2.ClH/c1-2-3-14-11-22-12-16-17(14)23-19(25)15(10-21)18(16)24-7-4-20(5-8-24)6-9-26-13-20;/h14,22H,2-9,11-13H2,1H3,(H,23,25);1H
Standard InChI Key: KNEYOZNYUDRJGI-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 356.47 | Molecular Weight (Monoisotopic): 356.2212 | AlogP: 2.24 | #Rotatable Bonds: 3 |
| Polar Surface Area: 81.15 | Molecular Species: BASE | HBA: 5 | HBD: 2 |
| #RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 7.05 | CX Basic pKa: 9.19 | CX LogP: -0.73 | CX LogD: -0.85 |
| Aromatic Rings: 1 | Heavy Atoms: 26 | QED Weighted: 0.87 | Np Likeness Score: -0.22 |
| 1. Meibom D, Micus S, Andreevski AL, Anlauf S, Bogner P, von Buehler CJ, Dieskau AP, Dreher J, Eitner F, Fliegner D, Follmann M, Gericke KM, Maassen S, Meyer J, Schlemmer KH, Steuber H, Tersteegen A, Wunder F.. (2022) BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor., 65 (24.0): [PMID:36475653] [10.1021/acs.jmedchem.2c01267] |
Source(1):
